In many cases of prostate cancer, changes of prostate volume were measured very frequently after castration by means of transrectal ultrasound.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
For short-term observations, a factor called as "reduction time (tau [τ])," which means the time required for the volume of "effective portion" (volume responded to castration) to be reduced to one-tenth of its original value, correlated very well with patients' prognosis. For long-term observations for relapse, changes of prostate volume could be divided clearly into two types, namely, "metastatic progressive type" with metastasis without volume increase and "local progressive type" with remarkable volume increase without metastasis. "τ" in the "local progressive type" was far shorter than that in the "metastatic progressive type."
Much longer survival was obtained when the patient belonged to the "local progressive type," than to the "metastatic progressive type." Thus, "τ" was the most important and the most reliable factor to predict the prognosis. Based upon these observations, a schematic analysis of prostate cancer relapse was shown.
Asian J Androl. 2015 Jun 30. doi: 10.4103/1008-682X.153543. [Epub ahead of print]
Director, Watanabe Memorial Choumei Research Laboratory, Shiga; Honorary Professor, Kyoto Prefectural University of Medicine and Meiji University of Integrated Medicine, Kyoto, Japan.